Zacks Research Brokers Lower Earnings Estimates for CORT
Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) – Stock analysts at Zacks Research lowered their Q1 2025 earnings per share (EPS) estimates for shares of Corcept Therapeutics in a research note issued to investors on Wednesday, March 19th. Zacks Research analyst K. Das now forecasts that the biotechnology company will post earnings per share of […]
Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) – Stock analysts at Zacks Research lowered their Q1 2025 earnings per share (EPS) estimates for shares of Corcept Therapeutics in a research note issued to investors on Wednesday, March 19th. Zacks Research analyst K. Das now forecasts that the biotechnology company will post earnings per share of […]
